Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,555.00
+10.00 (0.22%)
Feb 21, 2025, 9:00 AM KST

Yuyu Pharma Revenue

Yuyu Pharma had revenue of 33.60B KRW in the quarter ending September 30, 2024, a decrease of -1.44%. This brings the company's revenue in the last twelve months to 134.79B, down -1.86% year-over-year. In the year 2023, Yuyu Pharma had annual revenue of 137.21B, down -1.20%.

Revenue (ttm)
134.79B
Revenue Growth
-1.86%
P/S Ratio
0.55
Revenue / Employee
532.77M
Employees
253
Market Cap
73.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023137.21B-1.67B-1.20%
Dec 31, 2022138.88B23.23B20.08%
Dec 31, 2021115.66B17.54B17.87%
Dec 31, 202098.12B7.24B7.97%
Dec 31, 201990.88B7.78B9.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience 201.30B
Hanmi Pharm. 1,495.50B
Hanmi Science 1,283.65B
Hanall Biopharma 134.24B
Revenue Rankings